<div dir="auto"><div>The invention that you're talking about didn't come from AI but years of scientific research into the various uses of the skin of grapes </div><div dir="auto"> ilsa</div><div><br></div><div data-smartmail="gmail_signature"><div dir="ltr"><font color="#ffffff"><font color="#ff0000">Ilsa Bartlett</font></font><div><font color="#ffffff"><font color="#ff0000"><font color="#3333ff">Institute for Rewiring the System</font></font></font><br><a href="http://ilsabartlett.wordpress.com/" target="_blank">http://ilsabartlett.wordpress.com</a><br></div><div><a href="http://www.google.com/profiles/ilsa.bartlett" target="_blank">http://www.google.com/profiles/ilsa.bartlett</a><br><a href="http://www.hotlux.com/angel.htm" target="_blank">www.hotlux.com/angel</a><br><br>"Don't ever get so big or important that you can not hear and listen to every other person."<br>-John Coltrane</div></div></div></div><br><div class="gmail_quote gmail_quote_container"><div dir="ltr" class="gmail_attr">On Tue, Sep 8, 2026, 8:57 PM Stuart LaForge via extropy-chat <<a href="mailto:extropy-chat@lists.extropy.org">extropy-chat@lists.extropy.org</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0 0 0 .8ex;border-left:1px #ccc solid;padding-left:1ex">If that is so then patent law and copyright are diverging. There was a <br>
recent case regarding a graphic novel titled "Zarya of the Dawn" that <br>
only got limited copyright protection from the USPTO because the author <br>
Kris Kashtanova used Midjourney for the artwork. The layout and text <br>
were copyrightable, but the images were not. Also, I think that many if <br>
not most people choose not to distinguish between good AI-assisted art <br>
and AI slop, which is the difference between useful information and <br>
spam. There is a weird irrational element to the politics surrounding <br>
generative AI. The irrationality is a little reminiscent of "The <br>
Animatrix" prequel to "The Matrix" movie where the all human nations <br>
boycotted importing products from the machine nation because it was of <br>
higher quality than the human products.<br>
<br>
Stuart LaForge<br>
<br>
<br>
<br>
<br>
<br>
On 2026-09-08 13:54, Jason Resch via extropy-chat wrote:<br>
> My understanding is they can still patent it, just that they must list<br>
> only human names on the patent application where it asks for<br>
> inventors.<br>
> <br>
> There was an AI called the "invention machine" a few decades ago that<br>
> used genetic programming algorithms to find novel designs, which were<br>
> subsequently patented.<br>
> <br>
> What or methods were used to help find a certain technique or drug<br>
> isn't asked for on a patent applications today, and I suppose the<br>
> person who supplied the prompt could put their name down as the<br>
> inventor.<br>
> <br>
> Most journals are following a similar direction, they don't allow<br>
> adding AIs as authors even when they contribute substantially or more<br>
> than any human coauthor.<br>
> <br>
> Jason<br>
> <br>
> On Tue, Sep 8, 2026, 12:25 PM Stuart LaForge via extropy-chat<br>
> <<a href="mailto:extropy-chat@lists.extropy.org" target="_blank" rel="noreferrer">extropy-chat@lists.extropy.org</a>> wrote:<br>
> <br>
>> I am not against using AI to invent and generate intellectual<br>
>> property,<br>
>> but I wonder how the laws against it will affect things like drug<br>
>> development. I mean big pharma typically won't make a drug to combat<br>
>> a<br>
>> disease unless they can patent it. Are they going to make an<br>
>> exception<br>
>> in the new AI laws for large corporations?<br>
>> <br>
>> Stuart LaForge<br>
>> <br>
>> On 2026-09-07 12:25, John Clark via extropy-chat wrote:<br>
>>> Explore this gift article from The New York Times. You can read it<br>
>> for<br>
>>> free without a subscription.<br>
>>> <br>
>>> Early Data Indicates an A.I.-Generated Drug Could Slow Aging<br>
>>> <br>
>>> Artificial intelligence was used to help develop a drug candidate,<br>
>>> rentosertib, for a rare lung condition. Its maker says the drug<br>
>> also<br>
>>> seems to reduce the biological hallmarks of age.<br>
>>> <br>
>>> <br>
>> <br>
> <a href="https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share" rel="noreferrer noreferrer" target="_blank">https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share</a><br>
>> [1]<br>
>>> [1]<br>
>>> <br>
>>> Links:<br>
>>> ------<br>
>>> [1]<br>
>>> <br>
>> <br>
> <a href="https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share" rel="noreferrer noreferrer" target="_blank">https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share</a><br>
>> [1]<br>
>>> _______________________________________________<br>
>>> extropy-chat mailing list<br>
>>> <a href="mailto:extropy-chat@lists.extropy.org" target="_blank" rel="noreferrer">extropy-chat@lists.extropy.org</a><br>
>>> <a href="http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat" rel="noreferrer noreferrer" target="_blank">http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat</a><br>
>> _______________________________________________<br>
>> extropy-chat mailing list<br>
>> <a href="mailto:extropy-chat@lists.extropy.org" target="_blank" rel="noreferrer">extropy-chat@lists.extropy.org</a><br>
>> <a href="http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat" rel="noreferrer noreferrer" target="_blank">http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat</a><br>
> <br>
> <br>
> Links:<br>
> ------<br>
> [1] <br>
> <a href="https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share" rel="noreferrer noreferrer" target="_blank">https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html?unlocked_article_code=1._VA.LFye.Rv2JHNLQdgzL&smid=em-share</a><br>
> _______________________________________________<br>
> extropy-chat mailing list<br>
> <a href="mailto:extropy-chat@lists.extropy.org" target="_blank" rel="noreferrer">extropy-chat@lists.extropy.org</a><br>
> <a href="http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat" rel="noreferrer noreferrer" target="_blank">http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat</a><br>
_______________________________________________<br>
extropy-chat mailing list<br>
<a href="mailto:extropy-chat@lists.extropy.org" target="_blank" rel="noreferrer">extropy-chat@lists.extropy.org</a><br>
<a href="http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat" rel="noreferrer noreferrer" target="_blank">http://lists.extropy.org/mailman/listinfo.cgi/extropy-chat</a><br>
</blockquote></div>